Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 327 Neoplasm Metastasis 31 Advanced Breast Cancer 19 Neoplasms 17 Ovarian Neoplasms 11 Hereditary Sensory and Autonomic Neuropathies 10 Triple Negative Breast Neoplasms 8 Prostatic Neoplasms 7 Endometrial Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Breast Cancer Metastatic 6 Uterine Cervical Neoplasms 5 Breast Diseases 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms by Site 4 Colorectal Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Small Cell Lung Carcinoma 3 Recurrence 3 Multiple Endocrine Neoplasia Type 1 3 Head and Neck Neoplasms 3 Breast Neoplasm Female 3 Uterine Neoplasms 2 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Locally Advanced (Inoperable) or Metastatic Breast Cancer 2 Liposarcoma 2 Hyperglycemia 2 HER2-positive Metastatic Breast Cancer 2 HER2-positive Breast Cancer 2

Interventions

Sevoflurane 1 Propofol 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Female Breast Carcinoma × Fulvestrant × Breast × Clear all

NCT02540330 2024-04-03

007

Atossa Therapeutics, Inc.

Phase 2 Terminated

3 enrolled 7 charts

Female Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡